| Title | Authors / Editors | Date |
unige:89340 |
Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats |
Schraermeyer, U; Thumann, Gabriele; Luther, T; Kociok, N; ... Bartz-Schmidt, K U |
2001 |
unige:11063 |
Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people |
He, Qing; Li, Jian; Bettiol, Esther; Jaconi, Marisa |
2003 |
unige:39569 |
Xenotransplantation literature update September-October 2004 |
Baertschiger, Reto Marc; Buehler, Leo Hans |
2005 |
unige:11061 |
Genetic engineering of embryonic stem cells |
Suter, D. M.; Dubois-Dauphin, Michel; Krause, Karl-Heinz |
2006 |
unige:1974 |
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome |
Dietrich, Pierre-Yves; Duchosal, M A. |
2008 |
unige:1145 |
Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy |
Suter, David Michael; Krause, Karl-Heinz |
2008 |
unige:19860 |
Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study |
Hoekstra, Jildou; Leebeek, Frank W. G.; Plessier, Aurelie; Raffa, Sebastian; ... Janssen, Harry L. A. |
2009 |
unige:21010 |
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion |
Huenecke, Sabine; Zimmermann, Stefanie Yvonne; Kloess, Stephan; Esser, Ruth; ... Koehl, Ulrike |
2010 |
unige:21045 |
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA |
Kloess, Stephan; Huenecke, Sabine; Piechulek, Daniel; Esser, Ruth; ... Koehl, Ulrike |
2010 |
unige:24560 |
Introduction: Immunopathology and the promise of stem cell research |
Preynat-Seauve, Olivier; Villard, Jean |
2011 |
unige:25302 |
No improvement of survival with reduced - versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients |
Thiel, U |
2011 |
unige:99418 |
Chapter III: Management of cardiovascular risk factors and medical therapy |
Diehm, N; Schmidli, J; Setacci, C; Ricco, J-B; ... Apelqvist, J |
2011 |
unige:31670 |
Hémato-oncologie pédiatrique : de la biologie cellulaire aux traitements ciblés et individualisés |
von der Weid, Nicolas-Xavier; Ansari Djaberi, Marc Georges |
2012 |
unige:22841 |
The pharmaceutical biochemistry group: where pharmaceutical chemistry meets biology and drug delivery |
Kalia, Yogeshvar; Perozzo, Remo; Scapozza, Leonardo |
2012 |
unige:77142 |
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study |
Sester, Martina; van Leth, Frank; Bruchfeld, Judith; Bumbacea, Dragos; ... Lange, Christoph |
2014 |
unige:128688 |
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation |
Nava, Tiago; Kassir, Nastya; Rezgui, Mohamed Aziz; Uppugunduri Satyanarayana, Chakradhara Rao; ... Bittencourt, Henrique |
2018 |
unige:135517 |
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome |
Passet, Marie; Boissel, Nicolas; Sigaux, François; Saillard, Colombe; ... Clappier, Emmanuelle |
2019 |